Literature DB >> 16270355

Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin.

Bramanandam Manavathi1, Rakesh Kumar.   

Abstract

Estrogen mediate its biological effects through its association with estrogen receptors (ERs). They also regulate the expression of a variety of genes involved in distinct physiological processes, including development, metabolism, and reproduction. In addition, emerging data suggest that the estrogen-estrogen receptor complex can also function as a cytoplasmic signaling molecule and may influence processes such as cardiovascular protection, bone preservation, neuroprotection, and proliferation of various cell types. Such extranuclear or nongenomic signaling pathways are rapid and supposedly independent of transcription. A recent exciting finding was that G-coupled membrane protein receptor, GPR30, an alternative to the classical ERs, is also involved in the rapid signaling of estrogen through its direct association with estrogen. These new findings combined with the recent advances in the cytoplasmic functions of proline, glutamic acid, luecine rich protein 1 (PELP1), and metastatic tumor antigen 1 short form (MTA1s) have opened a new spectrum and raised several new concerns in the field of estrogen biology and put the attention to unveil many unknown mechanistic actions of estrogen in cellular physiology. In this review, we briefly summarize what is currently known of the cellular mechanisms and physiology of estrogen's nongenomic actions in various cellular systems used by ERs. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16270355     DOI: 10.1002/jcp.20551

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  47 in total

1.  Effects of oestrogen on microRNA expression in hormone-responsive breast cancer cells.

Authors:  Lorenzo Ferraro; Maria Ravo; Giovanni Nassa; Roberta Tarallo; Maria Rosaria De Filippo; Giorgio Giurato; Francesca Cirillo; Claudia Stellato; Silvana Silvestro; Concita Cantarella; Francesca Rizzo; Daniela Cimino; Olivier Friard; Nicoletta Biglia; Michele De Bortoli; Luigi Cicatiello; Ernesto Nola; Alessandro Weisz
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

Review 2.  Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds.

Authors:  Laszlo Prokai; James W Simpkins
Journal:  Pharmacol Ther       Date:  2007-02-02       Impact factor: 12.310

Review 3.  Review. Meiotic drive and sex determination: molecular and cytological mechanisms of sex ratio adjustment in birds.

Authors:  Joanna Rutkowska; Alexander V Badyaev
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-05-12       Impact factor: 6.237

4.  Post-transcriptional regulation of human breast cancer cell proteome by unliganded estrogen receptor β via microRNAs.

Authors:  Giovanni Nassa; Roberta Tarallo; Giorgio Giurato; Maria Rosaria De Filippo; Maria Ravo; Francesca Rizzo; Claudia Stellato; Concetta Ambrosino; Marc Baumann; Niina Lietzèn; Tuula A Nyman; Alessandro Weisz
Journal:  Mol Cell Proteomics       Date:  2014-02-13       Impact factor: 5.911

Review 5.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

Review 6.  PELP1: A novel therapeutic target for hormonal cancers.

Authors:  Dimple Chakravarty; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  IUBMB Life       Date:  2010-03       Impact factor: 3.885

7.  Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities.

Authors:  Paola Galluzzo; Maria Marino
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

8.  A role for GPRx, a novel GPR3/6/12-related G-protein coupled receptor, in the maintenance of meiotic arrest in Xenopus laevis oocytes.

Authors:  Diana Ríos-Cardona; Roberto R Ricardo-González; Ajay Chawla; James E Ferrell
Journal:  Dev Biol       Date:  2008-03-07       Impact factor: 3.582

9.  The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.

Authors:  Vladimir M Popov; Jie Zhou; L Andrew Shirley; Judy Quong; Wen-Shuz Yeow; Jennifer A Wright; Kongming Wu; Hallgeir Rui; Ratna K Vadlamudi; Jie Jiang; Rakesh Kumar; Chenguang Wang; Richard G Pestell
Journal:  Cancer Res       Date:  2009-07-15       Impact factor: 12.701

Review 10.  Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer.

Authors:  Jing Peng; Surojeet Sengupta; V Craig Jordan
Journal:  Anticancer Agents Med Chem       Date:  2009-06       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.